HRP20241515T1 - Kokristali (1r,3s)-3-(5-cijano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksilne kiseline - Google Patents

Kokristali (1r,3s)-3-(5-cijano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksilne kiseline Download PDF

Info

Publication number
HRP20241515T1
HRP20241515T1 HRP20241515TT HRP20241515T HRP20241515T1 HR P20241515 T1 HRP20241515 T1 HR P20241515T1 HR P20241515T T HRP20241515T T HR P20241515TT HR P20241515 T HRP20241515 T HR P20241515T HR P20241515 T1 HRP20241515 T1 HR P20241515T1
Authority
HR
Croatia
Prior art keywords
cocrystal
crystal
thiazol
cyano
phenyl
Prior art date
Application number
HRP20241515TT
Other languages
English (en)
Croatian (hr)
Inventor
Julio Castro Palomino Laria
Juan CAMACHO GÓMEZ
Original Assignee
Palobiofarma, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palobiofarma, S.L. filed Critical Palobiofarma, S.L.
Publication of HRP20241515T1 publication Critical patent/HRP20241515T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/02—Salts; Complexes; Addition compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HRP20241515TT 2020-03-16 2021-03-15 Kokristali (1r,3s)-3-(5-cijano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksilne kiseline HRP20241515T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20382194.7A EP3882240A1 (en) 2020-03-16 2020-03-16 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid
EP21710531.1A EP4121419B1 (en) 2020-03-16 2021-03-15 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid
PCT/EP2021/056506 WO2021185748A1 (en) 2020-03-16 2021-03-15 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid

Publications (1)

Publication Number Publication Date
HRP20241515T1 true HRP20241515T1 (hr) 2025-01-03

Family

ID=69953938

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20241515TT HRP20241515T1 (hr) 2020-03-16 2021-03-15 Kokristali (1r,3s)-3-(5-cijano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksilne kiseline

Country Status (21)

Country Link
US (1) US12384754B2 (cg-RX-API-DMAC10.html)
EP (2) EP3882240A1 (cg-RX-API-DMAC10.html)
JP (1) JP7779846B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220154791A (cg-RX-API-DMAC10.html)
CN (1) CN115298169B (cg-RX-API-DMAC10.html)
AU (1) AU2021237686B2 (cg-RX-API-DMAC10.html)
BR (1) BR112022018449A2 (cg-RX-API-DMAC10.html)
CA (1) CA3171894C (cg-RX-API-DMAC10.html)
DK (1) DK4121419T3 (cg-RX-API-DMAC10.html)
ES (1) ES3002084T3 (cg-RX-API-DMAC10.html)
FI (1) FI4121419T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20241515T1 (cg-RX-API-DMAC10.html)
HU (1) HUE068886T2 (cg-RX-API-DMAC10.html)
LT (1) LT4121419T (cg-RX-API-DMAC10.html)
MX (1) MX2022011530A (cg-RX-API-DMAC10.html)
PL (1) PL4121419T3 (cg-RX-API-DMAC10.html)
PT (1) PT4121419T (cg-RX-API-DMAC10.html)
RS (1) RS66214B1 (cg-RX-API-DMAC10.html)
SI (1) SI4121419T1 (cg-RX-API-DMAC10.html)
WO (1) WO2021185748A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202211247B (cg-RX-API-DMAC10.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331220B1 (es) * 2007-10-02 2010-09-23 Palobiofarma, S.L. Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
WO2011158110A2 (en) 2010-04-28 2011-12-22 Nuformix Limited Cilostazol cocrystals and compositions
LT3592734T (lt) 2017-03-06 2021-07-26 Palobiofarma, S.L. (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska

Also Published As

Publication number Publication date
PT4121419T (pt) 2024-11-18
KR20220154791A (ko) 2022-11-22
EP3882240A1 (en) 2021-09-22
EP4121419B1 (en) 2024-08-14
ES3002084T3 (en) 2025-03-06
HUE068886T2 (hu) 2025-02-28
SI4121419T1 (sl) 2025-02-28
WO2021185748A1 (en) 2021-09-23
LT4121419T (lt) 2024-11-25
RS66214B1 (sr) 2024-12-31
CN115298169B (zh) 2024-11-19
CN115298169A (zh) 2022-11-04
JP7779846B2 (ja) 2025-12-03
US20230183195A1 (en) 2023-06-15
CA3171894A1 (en) 2021-09-23
AU2021237686A1 (en) 2022-10-06
BR112022018449A2 (pt) 2022-11-01
DK4121419T3 (da) 2024-10-28
US12384754B2 (en) 2025-08-12
AU2021237686B2 (en) 2026-04-09
PL4121419T3 (pl) 2025-02-17
FI4121419T3 (fi) 2024-11-04
CA3171894C (en) 2025-03-11
JP2023517722A (ja) 2023-04-26
MX2022011530A (es) 2022-10-13
ZA202211247B (en) 2023-12-20
EP4121419A1 (en) 2023-01-25

Similar Documents

Publication Publication Date Title
JP6889311B2 (ja) Rafキナーゼおよび/またはRafキナーゼの二量体阻害剤としての縮合三環式ウレア系化合物
AU2018353722B2 (en) Composition for preventing or treating TNF-related diseases, containing novel derivative as active ingredient, and method for inhibiting TNF activity by using same
RU2569299C2 (ru) Композиции для модуляции киназного каскада и способы их применения
JP5975025B2 (ja) イミダゾピリジン化合物
CA2602328C (en) Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
US6617351B1 (en) Amide, carbamate, and urea derivatives
KR101982667B1 (ko) 신규한 유도체를 유효성분으로 포함하는 tnf-관련 질환 예방 또는 치료용 조성물 및 이를 이용한 tnf 활성 억제 방법
TWI333952B (en) Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
CN114206832A (zh) 拮抗lpa1受体的脲化合物
HUT65489A (en) Process for producing of indole derivatives and pharmaceutical compositions comprising them
WO2000006537A1 (en) N-substituted sulfonamide derivatives
SK2962002A3 (en) Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
JP2002521442A (ja) アミド、カルバメートおよび尿素誘導体
US10544103B2 (en) 5-HT2 antagonists
CA2863988C (en) 2-aryl/heteroarylbenzofuran-7-formamide compounds, preparation method and use thereof
TW201731824A (zh) α4β7整合蛋白抑制劑
AU774379B2 (en) Monofluoroalkyl derivatives
CN113831338A (zh) 一种组蛋白去乙酰化酶抑制剂及其制备方法和应用
CA3136535A1 (en) Benzo- and pyrido-pyrazoles as protein kinase inhibitors
CZ294233B6 (cs) Acylaminoalkenylenamidové deriváty, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
TW200951110A (en) Novel N-(2-amino-phenyl)-acrylamides
US20250289812A1 (en) Compound for treating thrombotic diseases
TW200804327A (en) Preventives/remedies for urinary disturbance
CN109293660A (zh) 吴茱萸次碱-no供体偶联物及其应用
JP2007186422A (ja) アリールスルフィド誘導体